Neuropsychiatric systemic lupus erythematosus: Miles to go before we sleep

Neurology

Volumn 61, Issue 1, 2003, Pages 9-10

  Brey, Robin L ^a   Petri, Michelle A ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; PHENOTHIAZINE; PHOSPHOLIPID ANTIBODY; PREDNISONE; SERUM ALBUMIN;

ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BRAIN ISCHEMIA; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; EDITORIAL; HEREDITY; HUMAN; HYPERGLYCEMIA; MANIA; MENTAL DISEASE; MYOPATHY; NEUROLOGIC DISEASE; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULAR DISEASE;

EID: 0038353633     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.61.1.9     Document Type: Editorial

References (10)

1. Rivest C, Lew R, Welsing P, et al. Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000;27:680-684.
2. American College of Rheumatology (ACR) ad hoc committee on neuropsychiatric lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 1999;42:599-608.
3. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003;61:108-110.
4. Chau SY, Mok CC. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 2003;61:104-107.
5. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-499.
6. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in SLE: prevalence using standardized definitions in the San Antonio Study of Neuropsychiatric Disease Cohort. Neurology 2002;58:1214-1220.
7. Costallat L, Bertolo M, Appenzeller S. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes: analysis of 527 patients. Lupus 2001;10:S32.
8. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999;42:728-734.
9. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
10. Lewis GP, Jusko WJ, Burke CW, et al. Prednisone side effects and serum protein levels. Lancet 1971;2:778-780.